Two agency letters put California-based Liveyon on warning and alert the public to the risks associated with stem-cell based therapies for autism.
Spectrum is an editorially independent division of the Simons Foundation Autism Research Initiative.
Autistic people have long maintained that repetitive behaviors are beneficial. Emerging evidence in support of this idea is shaping new therapies.
Editor-in-Chief
Deputy Editor
Features Editor
Multimedia Director
Copy Chief
Articles Editor
Senior News Writer
News Writer
Data Reporter
Engagement Editor
Editorial Assistant
Knight Science Journalism Program
New York University
The Washington Post
The New York Times Magazine
New York University
InsideClimate News
Stanford University
